Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

Amber Afzal; Mark A. Fiala; Meagan A. Jacoby; Matthew J. Walter

doi:10.1182/bloodadvances.2023009818

Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

Amber Afzal, Mark A. Fiala, Meagan A. Jacoby, Matthew J. Walter

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	3838-3841
Number of pages	4
Journal	Blood Advances
Volume	7
Issue number	15
DOIs	https://doi.org/10.1182/bloodadvances.2023009818
State	Published - Aug 8 2023

Access to Document

10.1182/bloodadvances.2023009818

Cite this

@article{52f348543300448595dc3d663e34059c,

title = "Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia",

author = "Amber Afzal and Fiala, {Mark A.} and Jacoby, {Meagan A.} and Walter, {Matthew J.}",

note = "Funding Information: Acknowledgments: This work was supported by grants from the Siteman Cancer Center, the Foundation for Barnes-Jewish Hospital Cancer Frontier Fund (5109), the Lottie Caroline Hardy Trust, the Edward P. Evans Center for Myelodysplastic Syndromes at Washington University, and the Edward P. Evans Foundation (to M.J.W.).",

year = "2023",

month = aug,

day = "8",

doi = "10.1182/bloodadvances.2023009818",

language = "English",

volume = "7",

pages = "3838--3841",

journal = "Blood Advances",

issn = "2473-9529",

number = "15",

}

TY - JOUR

T1 - Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

AU - Afzal, Amber

AU - Fiala, Mark A.

AU - Jacoby, Meagan A.

AU - Walter, Matthew J.

N1 - Funding Information: Acknowledgments: This work was supported by grants from the Siteman Cancer Center, the Foundation for Barnes-Jewish Hospital Cancer Frontier Fund (5109), the Lottie Caroline Hardy Trust, the Edward P. Evans Center for Myelodysplastic Syndromes at Washington University, and the Edward P. Evans Foundation (to M.J.W.).

PY - 2023/8/8

Y1 - 2023/8/8

UR - http://www.scopus.com/inward/record.url?scp=85170100350&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2023009818

DO - 10.1182/bloodadvances.2023009818

M3 - Letter

C2 - 37042968

AN - SCOPUS:85170100350

SN - 2473-9529

VL - 7

SP - 3838

EP - 3841

JO - Blood Advances

JF - Blood Advances

IS - 15

ER -

Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

Access to Document

Other files and links

Cite this